Advanced liver cancer: Selective internal radiation therapy
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
While advanced or inoperable hepatocellular carcinoma patients treated with selective internal radiation therapy showed similar overall survival to patients receiving sorafenib, it caused significantly fewer treatment-related adverse effects and delivered significantly better quality of life.

The French investigator-led SorAfenib versus Radioembolization in Advanced Hepatocellular Carcinoma (SARAH) trial - the first ever hepatocellular carcinoma (HCC) study of a liver-directed therapy against systemic chemotherapy - was recently presented at the International Liver Congress 2017, held in Amsterdam, the Netherlands......

http://www.medicalnewstoday.com/articles/317105.php
Preview
Like
Comment
Share